Literature DB >> 11706996

Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts.

S Akbar1, T Minor.   

Abstract

The use of marginal donor livers is followed by a higher frequency of primary dys- or nonfunction after transplantation. The present study was designed to test the hypothesis that stimulation of the cAMP second-messenger signal pathway might protect the liver from ischemic injury, laying emphasis on the role of protein kinase A-mediated signal transduction. Rat livers were harvested after 45 min of cardiac arrest and preserved in HTK solution for 24 h. Hepatic integrity was assessed thereafter using a blood-free reperfusion model. Supplementation of the preservation solution with dibutyryl-cAMP (db-cAMP) promoted phosphorylation of BAD at Ser 112 and concomitantly mitigated mitochondrial release of cytochrome c into the cytosol. Apoptotic cell transformation was evident in reperfused livers by positive TUNEL-staining of sinusoidal lining cells and the detection of cleaved poly(ADP-ribose) polymerase (PARP) in tissue homogenates by western analysis. Treatment with db-cAMP was effective in minimizing both TUNEL staining and PARP cleavage and significantly reduced postischemic enzyme leakage of alanine aminotransferase to one half, while hepatic bile production was enhanced by approximately 60% when compared to untreated livers. This functional improvement was accompanied by a net amelioration of portal vascular conductivity. Inhibition of A kinase-anchoring protein with HT31 completely reversed any of the observed effects obtained by db-cAMP. We conclude that enhancement of cellular cAMP signal maintains hepatic integrity during and after ischemic preservation which may be attributed to protein kinase A dependent phosphorylation of BAD in line with subsequent inhibition of mitochondria-initiated apoptosis of sinusoidal lining cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706996     DOI: 10.1007/PL00000808

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  7 in total

1.  Optimising post-conditioning time of marginal donor livers.

Authors:  Steffen Manekeller; Alexandra Seinsche; Judith Stegemann; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

2.  Role of changes in tissular nucleotides on the development of apoptosis during ischemia/reperfusion in rat small bowel.

Authors:  Meritxell Genescà; Anna Sola; Rosa Miquel; Felip Pi; Carme Xaus; Vicente Alfaro; Georgina Hotter
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair.

Authors:  Matthew Schnoke; Sharon B Midura; Ronald J Midura
Journal:  Bone       Date:  2009-05-18       Impact factor: 4.398

4.  CDK2 and PKA mediated-sequential phosphorylation is critical for p19INK4d function in the DNA damage response.

Authors:  Mariela C Marazita; M Florencia Ogara; Silvina V Sonzogni; Marcelo Martí; Nelson J Dusetti; Omar P Pignataro; Eduardo T Cánepa
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

5.  Proteomic analysis of tyrosine phosphorylation during human liver transplantation.

Authors:  Anouk Emadali; Peter P Metrakos; Fariba Kalantari; Tarek Boutros; Daniel Boismenu; Eric Chevet
Journal:  Proteome Sci       Date:  2007-01-02       Impact factor: 2.480

6.  Protective effect of HTK solution on postoperative pulmonary function in infants with CHD and PAH.

Authors:  Jindong Li; Yanhong Wu; Xudong Tian; Jiantang Wang; Mingfeng Dong; Anbiao Wang; Shengjun Ma
Journal:  Biosci Rep       Date:  2017-12-07       Impact factor: 3.840

Review 7.  Recent insights into mitochondrial targeting strategies in liver transplantation.

Authors:  Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Anabela Pinto Rolo; Carlos Marques Palmeira; José Guilherme Tralhão
Journal:  Int J Med Sci       Date:  2018-01-08       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.